More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC-Reference-Cited by-同舟云学术

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC

Published:2021-08-16 Issue:12 Volume:5 Page:1987-2000
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Zanetto Alberto¹²^ORCID,Campello Elena³,Bulato Cristiana³,Gavasso Sabrina³,Saggiorato Graziella³,Shalaby Sarah¹²,Spiezia Luca³,Cillo Umberto⁴,Farinati Fabio¹,Russo Francesco Paolo¹²^ORCID,Burra Patrizia¹²,Senzolo Marco¹²,Simioni Paolo³

Affiliation:

1. Gastroenterology Department of Surgery, Oncology, and Gastroenterology Padova University Hospital Padova Italy

2. Multivisceral Transplant Unit Department of Surgery, Oncology, and Gastroenterology Padova University Hospital Padova Italy

3. Thrombotic and Hemorrhagic Diseases Unit General Internal Medicine Padova University Hospital Padova Italy

4. Hepatobiliary Surgery and Liver Transplantation Center Department of Surgery, Oncology, and Gastroenterology Padova University Hospital Padova Italy

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1781

Reference50 articles.

1. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis

2. Hemostasis and thrombosis in patients with liver disease: The ups and downs

3. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

4. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo‐coagulable and Hyper‐coagulable Features

5. Current knowledge and management of portal vein thrombosis in cirrhosis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome;Digestive and Liver Disease;2024-08

2. “Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment;Journal of Thrombosis and Haemostasis;2024-08

3. FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription;Journal for ImmunoTherapy of Cancer;2024-07

4. Update on Coagulation Monitoring in Liver Transplantation;Current Anesthesiology Reports;2024-06-05

5. Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation;Digestive and Liver Disease;2024-06